W. Poewe

689 total citations
22 papers, 513 citations indexed

About

W. Poewe is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, W. Poewe has authored 22 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 3 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in W. Poewe's work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (7 papers) and Parkinson's Disease and Spinal Disorders (2 papers). W. Poewe is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (7 papers) and Parkinson's Disease and Spinal Disorders (2 papers). W. Poewe collaborates with scholars based in Austria, France and Portugal. W. Poewe's co-authors include Olivier Rascol, David J. Brooks, Fabrizio Stocchi, Amos D. Korczyn, Stefan Kiechl, Johann Willeit, Eberhard Gunsilius, Ursula Kiechl‐Kohlendorfer, Florian Deisenhammer and S. Felber and has published in prestigious journals such as Neurology, Movement Disorders and Journal of the Neurological Sciences.

In The Last Decade

W. Poewe

20 papers receiving 495 citations

Peers

Countries citing papers authored by W. Poewe

Since Specialization

Citations

This map shows the geographic impact of W. Poewe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Poewe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Poewe more than expected).

Fields of papers citing papers by W. Poewe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Poewe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Poewe. The network helps show where W. Poewe may publish in the future.

Co-authorship network of co-authors of W. Poewe

This figure shows the co-authorship network connecting the top 25 collaborators of W. Poewe. A scholar is included among the top collaborators of W. Poewe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Poewe. W. Poewe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstracts of the MDS Virtual Congress 2021 2021 ·Movement Disorders ·Anthony E. Lang, (unknown), Eric A. Macklin, W. Poewe, David J. Brooks	7
2	Nighttime and morning OFF improvements with opicapone in patients with Parkinson's Disease and motor fluctuations: BIPARK-1 and BIPARK-2 pooled subanalyses 2020 ·Parkinsonism & Related Disorders ·R. Hauser, Mark Lew, Cynthia L. Comella, W. Poewe, Olivier Rascol, (unknown), Kara Olson, (unknown), Chetan Shah, José‐Francisco Rocha, Patrício Soares‐da‐Silva, Olga Klepitskaya	2
3	Efficacy of opicapone in Parkinson’s disease patients with ‘early’ motor fluctuations: Patient and clinical global impression of change from the BIPARK-I double-blind experience 2019 ·Journal of the Neurological Sciences ·(unknown), Fabrizio Stocchi, Andrew J. Lees, Joaquim J. Ferreira, W. Poewe, Olivier Rascol, A. Santos, D. Magalhães, Patrício Soares‐da‐Silva	1
4	Atypische Parkinson-Syndrome - Aktuelles aus Diagnostik und Therapie 2012 ·Fortschritte der Neurologie · Psychiatrie ·Susanne Duerr, Gregor K. Wenning, Klaus Seppi, W. Poewe	0
5	2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE 2011 ·Parkinsonism & Related Disorders ·W. Poewe, Paolo Barone, R. Hauser, Y Mizuno, Olivier Rascol, Michael Busse, C. Debieuvre, Mandy Fraessdorf, Anthony H.V. Schapira	1
6	Sustained efficacy and tolerability of pramipexole extended-release as adjunctive treatment in advanced Parkinson's disease 2010 ·UCL Discovery (University College London) ·Anthony H.V. Schapira, Paolo Barone, (unknown), Y Mizuno, Olivier Rascol, Michael Busse, Laurence Salin, Mandy Sohr, W. Poewe	1
7	Pramipexole for the treatment of depressive symptoms in patients with Parkinson disease: a randomized, double blind, placebo controlled trial 2010 ·Paolo Barone, W. Poewe, Stefan Albrecht, (unknown), Dan Massey, Olivier Rascol, E. Tolosa, (unknown)	15
8	P2.152 Changes in early-morning motor status following adjunctive treatment of advanced Parkinson's disease with rotigotine transdermal system: two large, placebo-controlled trials 2009 ·Parkinsonism & Related Disorders ·Rajesh Pahwa, W. Poewe, Kelly Lyons, Babak Boroojerdi	5
9	W01.41 Osteoprotegerin is a risk predictor of progressive atherosclerosis and cardiovascular disease 2004 ·Atherosclerosis Supplements ·Sophia J. Kiechl, G. Schett, W. Poewe, Johann Willeit	3
10	Juvenile asymmetric segmental spinal muscular atrophy (Hirayama's disease) Three cases without evidence of “flexion myelopathy” 2001 ·Acta Neurologica Scandinavica ·Johann Willeit, Stefan Kiechl, Ursula Kiechl‐Kohlendorfer, S. Golaszewski, S. Peer, W. Poewe	43
11	Vascular endothelial growth factor in CSF 2000 ·Neurology ·Günther Stockhammer, W. Poewe, (unknown), Florian Deisenhammer, Armin Muigg, Stefan Kiechl, Erich Schmutzhard, Hans Maier, S. Felber, Paul Schumacher, Eberhard Gunsilius, Günther Gastl	84
12	Reversible severe myopathy of respiratory muscles due to adult-onset type III glycogenosis 1999 ·Neuromuscular Disorders ·Stefan Kiechl, Johann Willeit, Wichard Vogel, (unknown), W. Poewe	20
13	Ropinirole in the treatment of early Parkinson's disease: A 6‐month interim report of a 5‐year levodopa‐controlled study 1998 ·Movement Disorders ·Olivier Rascol, David J. Brooks, (unknown), Amos D. Korczyn, W. Poewe, Fabrizio Stocchi	161
14	Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study 1998 ·Movement Disorders ·Amos D. Korczyn, David J. Brooks, (unknown), W. Poewe, Olivier Rascol, Fabrizio Stocchi	101
15	Natural history of Parkinson's disease 1998 ·Pathophysiology ·W. Poewe	1
16	Magnetresonanztomographie bei Patienten mit Morbus Parkinson und Parkinson-Plus-Syndromen 1996 ·RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren ·Johannes Hierholzer, Anette Schrag, M. Cordes, B. Sander, Ludwig Schelosky, (unknown), S. Venz, U. Keske, J. Mäurer, W. Poewe, R Felix	1
17	Memory dysfunction in Parkinson patients: an analysis of verbal learning processes 1991 ·PubMed ·(unknown), J. Ilmberger, W. Poewe, F Gerstenbrand	7
18	Visuoperception and visuospatial and visuorotational performance in Parkinson's disease 1987 ·Journal of Neurology ·Gerhard Ransmayr, (unknown), (unknown), (unknown), W. Poewe, (unknown)	27
19	[Clinical subtypes of Parkinson disease]. 1986 ·PubMed ·W. Poewe, F Gerstenbrand	8
20	[Double bilateral carotid artery occlusion after blunt neck trauma (case report)]. 1981 ·PubMed ·S Weimann, (unknown), A. Pallua, W. Poewe	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact